Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01717521 · ClinicalTrials.gov registry record
Effects of IV Administration of Ketamine on the Analgesia Nociception Index (ANI) Measured With the PhysioDoloris
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 20
- Enrollment target
NCT01717521: Completed study, sponsored by University of Washington.
NCT01717521 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01717521 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study evaluates effects of the analgesic ketamine on ANI measurements (Anti Nociceptive Index)
Primary Outcome
ANI stands for Analgesia Nociception Index. Its a dimension less number computed by a pain monitor ranging from 0-100. An index of 100 means absent pain, and the number decreases as pain increases. ANI was measured pre- and post- Intubation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-08 |
| Est. Completion | 2012-12 |
What the finished NCT01717521 record still lists
NCT01717521 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01717521 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01717521 about?
NCT01717521 is a clinical study titled "Effects of IV Administration of Ketamine on the Analgesia Nociception Index (ANI) Measured With the PhysioDoloris". This study evaluates effects of the analgesic ketamine on ANI measurements (Anti Nociceptive Index)
What is the current status of trial NCT01717521?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-08. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01717521?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia